MICHELLE COCHRAN: Open Payments
NPI 1760587026 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,579 in 26 payments from 9 companies in 2025. Trend: 2023 $28,367 · 2024 $5,243 · 2025 $11,579
Speaker / faculty: $9,810Travel & lodging: $1,020Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 14 | $11,191 |
| LivaNova USA, Inc. | 1 | $154 |
| Alkermes, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| ABBVIE INC. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $19 |
Products named: SPRAVATO, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, ARISTADA, COBENFY, CAPLYTA, VRAYLAR, Auvelity, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
